An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint Seung-Ho KongSangmee LeeChul W. Ahn Clinical Trials 31 December 2008 Pages: 527 - 535
The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials Harold E. Gloss Clinical Trials 31 December 2008 Pages: 537 - 543
Confirm and Explore: A Stepwise Approach to Clinical Study Designs Naitee Ting Clinical Trials 31 December 2008 Pages: 545 - 554
Publishing a Drug Information Bulletin: Experiences From a Developing Country P. Ravi ShankarP. SubishPranaya Mishra Drug Information 31 December 2008 Pages: 555 - 559
Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis Yuanjia HuYing BianYitao Wang Drug Information 31 December 2008 Pages: 561 - 568
Legal Requirements for Drug Information Resources Maintained by Pharmacies Kevin A. ClausonJennifer A. FassMatthew J. Seamon Drug Information 31 December 2008 Pages: 569 - 582
A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications Michiko YamamotoTakeo Nakayama Drug Information 31 December 2008 Pages: 583 - 596
Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value Lee KaiserJeffrey HelterbrandHal Barron Statistics 31 December 2008 Pages: 597 - 606
A Noninferiority Margin for Acne Lesion Counts Christoph GerlingerGerald StädtlerJan Endrikat Statistics 31 December 2008 Pages: 607 - 615
Statistical Test for Ordered Categorical Data in Clinical Trials Shein-Chung ChowSiu-Keung TseEric Chi Statistics 31 December 2008 Pages: 617 - 624
How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? Steven A. JuliousSue-Jane Wang Statistics 31 December 2008 Pages: 625 - 633
A Review of Pharmacoepidemiology and Therapeutic Risk Management Steven F. Hoff Book Review 31 December 2008 Pages: 635 - 636